Morgan Stanley’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.5M | Sell |
|
|||||
|
2025
Q4 | $13.8M | Buy |
|
|||||
|
2025
Q3 | $1.84M | Buy |
|
|||||
|
2025
Q2 | $2.04M | Sell |
|
|||||
|
2025
Q1 | $2.12M | Buy |
|
|||||
|
2024
Q4 | $2.55M | Sell |
|
|||||
|
2024
Q3 | $6.58M | Buy |
|
|||||
|
2024
Q2 | $3.04M | Sell |
|
|||||
|
2024
Q1 | $11.5M | Buy |
|
|||||
|
2023
Q4 | $8.03M | Buy |
|
|||||
|
2023
Q3 | $539K | Sell |
|
|||||
|
2023
Q2 | $8.13M | Buy |
|
|||||
|
2023
Q1 | $696K | Buy |
|
|||||
|
2022
Q4 | $287K | Buy |
|
|||||
|
2022
Q3 | $24K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $133K | Hold |
|
|||||
|
2021
Q3 | $132K | Buy |
|
|||||
|
2021
Q2 | $61K | Sell |
|
|||||
|
2021
Q1 | $60K | Buy |
|
|||||
|
2020
Q4 | $0 | Buy |
|